Borys Hrinczenko
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Immunology top 10%
- Cancer Research top 10%
- Molecular Biology
- Co-authors
- Petros NikolinakosRalph V. BocciaRobert A. SomerGuy JérusalemIstván TakácsAndres Forero‐TorresJayne S. GurtlerH. Grote
- Topics
- Cancer Immunotherapy and Biomarkers (7 papers)Lung Cancer Treatments and Mutations (7 papers)Colorectal Cancer Treatments and Studies (6 papers)
- Partner nations
- United StatesGermanyGrenada
In The Last Decade
Borys Hrinczenko
23 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 735
- Pulmonary and Respiratory Medicine 372
- Immunology 234
- Cancer Research 178
- Molecular Biology 159
Countries citing papers authored by Borys Hrinczenko
This map shows the geographic impact of Borys Hrinczenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Borys Hrinczenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Borys Hrinczenko more than expected).
Fields of papers citing papers by Borys Hrinczenko
This network shows the impact of papers produced by Borys Hrinczenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Borys Hrinczenko. The network helps show where Borys Hrinczenko may publish in the future.
Co-authorship network of co-authors of Borys Hrinczenko
This figure shows the co-authorship network connecting the top 25 collaborators of Borys Hrinczenko. A scholar is included among the top collaborators of Borys Hrinczenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Borys Hrinczenko. Borys Hrinczenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 6 | |
| 6 | 0 | |
| 7 | 80 | |
| 8 | 0 | |
| 9 | 12 | |
| 10 | 6 | |
| 11 | Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor studybreakdown → | 581 |
| 12 | 121 | |
| 13 | 120 | |
| 14 | 1 | |
| 15 | 0 | |
| 16 | 2 | |
| 17 | 21 | |
| 18 | 23 | |
| 19 | 20 | |
| 20 | 101 |
About Borys Hrinczenko
Borys Hrinczenko is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Oncology (735 citations), Cancer Research (178 citations) and Pulmonary and Respiratory Medicine (372 citations). Borys Hrinczenko has collaborated with scholars based in United States, Germany and Grenada. Frequent co-authors include Petros Nikolinakos, Ralph V. Boccia, Robert A. Somer, Guy Jérusalem, István Takács, Andres Forero‐Torres, Jayne S. Gurtler, H. Grote, Anja von Heydebreck and Luc Dirix. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.